Wachira Joins US Pharmacopeia

July 27, 2006
BioPharm International Editors

Catherine Wachira has joined The US Pharmacopeia (USP, www.usp.org), as director of the Drug Quality and Information (DQI) program.

Catherine Wachira has joined The US Pharmacopeia (USP, www.usp.org), as director of the Drug Quality and Information (DQI) program. USP’s DQI program provides assistance in drug quality assurance, develops and disseminates drug and therapeutic information, trains laboratory staff, and provides scientific evidence for healthcare decision-making in developing countries. Wachira previously served as director of clinical research for Callisto Pharmaceuticals.